EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-1R2 as a Precision Therapeutic Target in Sepsis: Molecular Insights into Immune Regulation

Kirtan Dave iD, Cristian R Munteanu iD

Current Issues in Molecular Biology · 06.06.2025 · 47 (6) · 429

DOI: 10.3390/cimb47060429 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 06.06.2025. Verfasst von Kirtan Dave und 1 weiteren Autor:innen. Beteiligte Einrichtung: Parul Institute of Applied Sciences, Parul University, Vadodara 391760, Gujarat, India. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis is a life-threatening condition characterized by systemic inflammation and organ dysfunction, with a complex and not yet fully elucidated molecular basis. Central to its pathogenesis is a dysregulated immune response. In this study, we performed a comprehensive multi-omics analysis on transcriptomic datasets retrieved from the GEO database, including samples from sepsis patients (n = 23) and healthy controls (n = 27). and identified a pivotal role of Interleukin-1 receptor 2 (IL-1R2) in modulating inflammatory responses in sepsis. Transcriptomic integration revealed activation of critical signaling pathways, including NFκB/NLRP3, associated with sepsis-induced immune dysregulation. We identified a pivotal role of Interleukin-1 receptor 2 (IL-1R2) in modulating inflammatory responses in sepsis, with IL-1R2 showing a 2.1-fold upregulation in septic patients. Transcriptomic integration revealed the activation of 42 significantly enriched signaling pathways, with 26 upregulated and 26 downregulated pathways. Notably, the NFκB/NLRP3 signaling axis emerged as a central hub of immune dysregulation. Gene Ontology (GO) enrichment analysis highlighted “neutrophil activation involved in immune response” as the top biological process. Our findings suggest that IL-1R2 functions as a key immunoregulatory molecule and represents a promising therapeutic target. Moreover, we observed distinct patterns of oxidative stress regulation and immune cell activation, with potential biomarkers correlating with disease severity. These insights not only enhance the molecular understanding of sepsis but also point toward novel precision therapeutic strategies focused on modulating inflammation to improve patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

IL-1R2NFκB signalingbiomarkersimmune responseinflammationsepsistherapeutic targets

Autor:innen und Institutionen

  • Parul Institute of Applied Sciences, Parul University, Vadodara 391760, Gujarat, India.
  • Bioinformatics Laboratory, Research & Development Cell, Parul University, Vadodara 391760, Gujarat, India.
  • RNASA, Computer Science Faculty, University of A Coruña, 15071 A Coruña, Spain.

ORCID-Profile: Kirtan Dave, Cristian R Munteanu

Zitieren

APA

Dave, K., & Munteanu, C. R. (2025). IL-1R2 as a Precision Therapeutic Target in Sepsis: Molecular Insights into Immune Regulation. Current Issues in Molecular Biology, 47(6), 429. https://doi.org/10.3390/cimb47060429

Vancouver

Dave K, Munteanu CR. IL-1R2 as a Precision Therapeutic Target in Sepsis: Molecular Insights into Immune Regulation. Current Issues in Molecular Biology. 2025;47(6):429. doi:10.3390/cimb47060429

BibTeX
@article{Dave2025,
  author = {Dave, Kirtan and Munteanu, Cristian R},
  title = {IL-1R2 as a Precision Therapeutic Target in Sepsis: Molecular Insights into Immune Regulation},
  journal = {Current Issues in Molecular Biology},
  year = {2025},
  volume = {47},
  number = {6},
  pages = {429},
  doi = {10.3390/cimb47060429}
}
Kostenlos starten →